➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Boehringer Ingelheim
Express Scripts
McKesson
Mallinckrodt

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Henagliflozin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Henagliflozin?

Henagliflozin is an investigational drug.

There have been 5 clinical trials for Henagliflozin. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2013.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2 and [disabled in preview]. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd. and [disabled in preview].

There is one US patent protecting this investigational drug and nine international patents.

Recent Clinical Trials for Henagliflozin
TitleSponsorPhase
Drug-drug Interaction Between Simvastatin and SHR3824Jiangsu HengRui Medicine Co., Ltd.Phase 1
The Drug-drug Interaction of SHR3824 and SP2086Jiangsu HengRui Medicine Co., Ltd.Phase 1
The Drug-drug Interaction of SHR3824 and MetforminJiangsu HengRui Medicine Co., Ltd.Phase 1

See all Henagliflozin clinical trials

Clinical Trial Summary for Henagliflozin

Top disease conditions for Henagliflozin
Top clinical trial sponsors for Henagliflozin

See all Henagliflozin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Boehringer Ingelheim
Express Scripts
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.